Author: FX
In the world of forex trading, precision and timing are of utmost importance. Traders are constantly on the lookout for tools and indicators that can help them make informed decisions. One such tool that has gained popularity in recent times is the Fractals Arrows Alert MT4 Indicator. In this article, we will delve into the intricacies of this indicator, exploring its functionality, significance, and how traders can leverage it to enhance their trading strategies. Understanding Fractals What Are Fractals in Forex Trading? Before we dive into the specifics of the Fractals Arrows Alert MT4 Indicator, let’s first grasp the concept…
If artificial intelligence is the future, then Sam Altman was the man delivering it.The CEO of OpenAI, which created ChatGPT, was unceremoniously given his pink slip today. The company released a statement that said:Mr. Altman’s departure follows a deliberative review process by the board, which concluded that he was not consistently candid in his communications with the board, hindering its ability to exercise its responsibilities. The board no longer has confidence in his ability to continue leading OpenAI.The company said that chief technology officer Mira Murati would take his place on an interim basis.In a statement, the board of directors…
The Aussie led the pack with Australian data pointing to persistent inflation, while USD lagged due to emerging signs of declining inflation in the U.S. Source link
Aligos Therapeutics files to sell 168.73M shares of common stock Source link
High risk warning: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all your initial investment; do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading and seek advice from an independent financial or tax advisor if you have any questions. Advisory warning: FOREXLIVE™ is not an investment advisor, FOREXLIVE™ provides references and…
Share: The AUD/JPY saw a late break higher in Friday’s broad-market sentiment recovery. The Aussie is catching a bounce from the 200-hour SMA and a rising trendline. The technicals are leaning bullish with more upside on the cards, but headwinds remain. The AUD/JPY snuck over the 97.50 level just ahead of the Friday closing bell, trying to claw back some of the midweek’s losses after the pair tumbled from a Wednesday peak of 98.66. The AUD/JPY closed out the trading week with some gains, up nearly 1.2% from Monday’s opening bids near 96.40, but the back half of…
Share: NZD/JPY was down by 0.40% on Friday and closed a 0.40% weekly gain. Buyers continue to be on the sidelines after pushing the pair to multi-year highs this week. Indicators are losing momentum on the daily chart. In Friday’s session, the NZD/JPY cross extended its decline towards 89.65 as investors continued to take profits from Tuesday and Wednesday’s rally, which took the pair to its highest level since 2015. The daily Relative Strength Index (RSI) points south, above the 50 middle points, while the Moving Average Convergence Divergence (MACD) prints lower green bars, evidencing the buyers are taking…
Share: The CAD caught a bounce on risk appetite in early Friday trading. Industrial inflation figures in Canada print better than expected. US Dollar, Fed reaction is driving the market today. The Canadian Dollar (CAD) is looking to pare back some of Thursday’s losses, catching some support from bolstered Crude Oil bids, but downside risks remain. The Loonie is up about half a percent against the US Dollar (USD) for the week. Canadian industrial inflation figures went head-to-head with US housing data Friday morning, but overall, risk sentiment appears to be the primary driver of moment-to-moment market moves.…
© Reuters. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo (Reuters) – The U.S. health regulator’s advisers on Friday did not recommend Merck’s drug for the treatment of chronic cough. The FDA panel voted 12 to 1 that the data presented does not demonstrate substantial evidence of effectiveness of the oral tablet, gefapixant, for the treatment of refractory or unexplained chronic cough. Source link
Share: The EUR/CHF is seeing a late break heading into Friday’s closing bell. Market sentiment is seeing a late-week rally as investors take one last dip into the risk well. The EUR/CHF pair is up 0.40% bottom-to-top as risk appetite makes a late recovery. The EUR/CHF dipped to a new low for the week at 0.9623 in early Friday trading before markets saw a broad-base tilt back into risk-on mode, pushing risk assets higher and sending safe havens lower to round out the week’s trading. Pan-EU finalized Harmonized Index of Consumer Prices (HICP) for October came in broadly…